Mir Imran, Rani Therapeutics

Rani Ther­a­peu­tics eyes po­ten­tial IPO as ro­bot­ic pill tech­nol­o­gy takes shape

Two ef­forts to trans­form in­jecta­bles in­to ro­bot­ic pills — a colos­sal mar­ket de­signed to en­hance treat­ment com­pli­ance, di­min­ish the need for physi­cian-led ther­a­peu­tic ad­min­is­tra­tion and pla­cate nee­dle-pho­bic pa­tients — got off the ground last year. Now, one of these ini­tia­tives, led by an in­ven­tor who played an in­flu­en­tial role in pi­o­neer­ing the first FDA-ap­proved au­to­mat­ic im­plantable car­diovert­er de­fib­ril­la­tor (ICD) has tak­en an­oth­er key step in its quest with a suc­cess­ful ear­ly-stage ef­fi­ca­cy and safe­ty study.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.